{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:03:18Z","timestamp":1784026998656,"version":"3.55.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.rmed.2023.107499","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:35:41Z","timestamp":1702654541000},"page":"107499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Potential systemic effects of acquired CFTR dysfunction in COPD"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-9520","authenticated-orcid":false,"given":"Marc","family":"Miravitlles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Criner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus F.","family":"Vogelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schoenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.rmed.2023.107499_bib2","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCP.0000000000000145","article-title":"The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications","volume":"21","author":"Kim","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.202006-2248OC","article-title":"Mucus plugs and emphysema in the pathophysiology of airflow obstruction and hypoxemia in smokers","volume":"203","author":"Dunican","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arbres.2011.10.007","article-title":"Clinical phenotypes of COPD: identification, definition and implications for guidelines","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch. Bronconeumol."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib7","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jaci.2018.02.035","article-title":"Chronic obstructive pulmonary disease subpopulations and phenotyping","volume":"141","author":"Segal","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2008.110619","article-title":"Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk","volume":"64","author":"Guerra","year":"2009","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02470-2016","article-title":"Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease","volume":"50","author":"Lahousse","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2023.107499_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/ijcp.12248","article-title":"Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study","volume":"67","author":"Corhay","year":"2013","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.chest.2019.03.041","article-title":"The st. George's respiratory questionnaire definition of chronic bronchitis may Be a better predictor of COPD exacerbations compared with the classic definition","volume":"156","author":"Kim","year":"2019","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.rmed.2011.02.003","article-title":"Cough and sputum production as risk factors for poor outcomes in patients with COPD","volume":"105","author":"Miravitlles","year":"2011","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/resp.12642","article-title":"COPD and its comorbidities: impact, measurement and mechanisms","volume":"20","author":"Negewo","year":"2015","journal-title":"Respirology"},{"issue":"130","key":"10.1016\/j.rmed.2023.107499_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Cavaill\u00e8s","year":"2013","journal-title":"Eur. Respir. Rev."},{"issue":"10082","key":"10.1016\/j.rmed.2023.107499_bib15","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","article-title":"Chronic obstructive pulmonary disease","volume":"389","author":"Rabe","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00228013","article-title":"CFTR: cystic fibrosis and beyond","volume":"44","author":"Mall","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccm.2015.11.003","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction in chronic bronchitis and other diseases of mucus clearance","volume":"37","author":"Raju","year":"2016","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2023.107499_bib19","article-title":"Airway epithelium dysfunction in cystic fibrosis and COPD","volume":"2018","author":"De Rose","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/lio2.401","article-title":"Chronic rhinosinusitis in patients with cystic fibrosis-Current management and new treatments","volume":"5","author":"Johnson","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.rmed.2023.107499_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106092","article-title":"Chronic rhinosinusitis in COPD: a prevalent but unrecognized comorbidity impacting health related quality of life","volume":"171","author":"Arndal","year":"2020","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/physrev.00007.2018","article-title":"STRUCTURE, gating, and regulation of the CFTR anion channel","volume":"99","author":"Csan\u00e1dy","year":"2019","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4187\/aarc0443","article-title":"Pulmonary complications of cystic fibrosis","volume":"54","author":"Flume","year":"2009","journal-title":"Respir. Care"},{"issue":"10059","key":"10.1016\/j.rmed.2023.107499_bib24","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib26","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","article-title":"Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers","volume":"173","author":"Cantin","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1465-9921-15-69","article-title":"Accumulation of metals in GOLD4 COPD lungs is associated with decreased CFTR levels","volume":"15","author":"Hassan","year":"2014","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01307-2022","article-title":"Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond","volume":"61","author":"Mall","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"20","key":"10.1016\/j.rmed.2023.107499_bib31","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMra1813799","article-title":"Muco-obstructive lung diseases","volume":"380","author":"Boucher","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082891","article-title":"Cystic fibrosis, CFTR, and colorectal cancer","volume":"21","author":"Scott","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17476348.2018.1475235","article-title":"CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease","volume":"12","author":"Fernandez Fernandez","year":"2018","journal-title":"Expet Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/AnnalsATS.201909-671CME","article-title":"The extrapulmonary effects of cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"17","author":"Sergeev","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2023.107499_bib35","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11030572","article-title":"Cystic fibrosis-related diabetes (CFRD): overview of associated genetic factors","volume":"11","author":"Iafusco","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.rmed.2023.107499_bib39","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/MPA.0000000000001145","article-title":"Pancreatitis-associated genes and pancreatic cancer risk: a systematic review and meta-analysis","volume":"47","author":"Cazacu","year":"2018","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.rmed.2023.107499_bib40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.dld.2017.06.013","article-title":"Association between F508 deletion in CFTR and chronic pancreatitis risk","volume":"49","author":"Zhao","year":"2017","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107845","article-title":"Effect of CFTR modulator therapy on cystic fibrosis-related diabetes","volume":"35","author":"Gaines","year":"2021","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.rmed.2023.107499_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.852551","article-title":"Short-term effects of elexacaftor\/tezacaftor\/ivacaftor combination on glucose tolerance in young people with cystic fibrosis-an observational pilot study","volume":"10","author":"Korten","year":"2022","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib43","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11030649","article-title":"Intestinal inflammation and alterations in the gut microbiota in cystic fibrosis: a review of the current evidence, pathophysiology and future directions","volume":"11","author":"Tam","year":"2022","journal-title":"J. Clin. Med."},{"issue":"32","key":"10.1016\/j.rmed.2023.107499_bib45","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1038\/onc.2015.483","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"35","author":"Than","year":"2016","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.rmed.2023.107499_bib46","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"De Lisle","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2023.107499_bib47","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jcf.2017.06.013","article-title":"Cystic Fibrosis & disorders of the large intestine: DIOS, constipation, and colorectal cancer","volume":"16","author":"Abraham","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0000000000000432","article-title":"Liver disease in patients with cystic fibrosis","volume":"34","author":"Kamal","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib49","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hep.28817","article-title":"The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity","volume":"64","author":"Fiorotto","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcf.2021.07.014","article-title":"The impact of liver disease on mortality in cystic fibrosis-A systematic review","volume":"21","author":"Sasame","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2023.107499_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.611921","article-title":"Bone cells differentiation: how CFTR mutations may rule the game of stem cells commitment?","volume":"9","author":"Dumortier","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.rmed.2023.107499_bib52","article-title":"Treatment of cystic fibrosis related bone disease","volume":"27","author":"Ullal","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2023.107499_bib53","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jcf.2019.08.018","article-title":"Cystic fibrosis bone disease: pathophysiology, assessment and prognostic implications","volume":"18","author":"Anabtawi","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/humupd\/dms027","article-title":"Regulation of male fertility by CFTR and implications in male infertility","volume":"18","author":"Chen","year":"2012","journal-title":"Hum. Reprod. Update"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4081\/aiua.2014.3.171","article-title":"Impact of cystic fibrosis transmembrane regulator (CFTR) gene mutations on male infertility","volume":"86","author":"Elia","year":"2014","journal-title":"Arch. Ital. Urol. Androl."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib56","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.chest.2021.07.024","article-title":"Fertility and pregnancy in cystic fibrosis","volume":"160","author":"Shteinberg","year":"2021","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rmed.2023.107499_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092706","article-title":"CFTR modulators: impact on fertility, pregnancy, and lactation in women with cystic fibrosis","volume":"9","author":"Taylor-Cousar","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib58","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.21037\/tau.2020.04.05","article-title":"Genetics of CFTR and male infertility","volume":"10","author":"Bieniek","year":"2021","journal-title":"Transl. Androl. Urol."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2018.10.009","article-title":"Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age","volume":"18","author":"Shteinberg","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2020.12.011","article-title":"Elexacafator\/tezacaftor\/ivacaftor resolves subfertility in females with CF: a two center case series","volume":"20","author":"O'Connor","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2023.107499_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.mod.2020.103627","article-title":"CFTR deficiency causes cardiac dysplasia during zebrafish embryogenesis and is associated with dilated cardiomyopathy","volume":"163","author":"Liu","year":"2020","journal-title":"Mech. Dev."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcf.2021.04.016","article-title":"Cardiovascular complications in cystic fibrosis: a review of the literature","volume":"21","author":"Poore","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2023.107499_bib63","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0112-2021","article-title":"Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy","volume":"17","author":"Tewkesbury","year":"2021","journal-title":"Breathe"},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib65","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S2213-2600(16)30047-9","article-title":"Pilot evaluation of ivacaftor for chronic bronchitis","volume":"4","author":"Solomon","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib66","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","article-title":"Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications","volume":"201","author":"Mall","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86183","article-title":"Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities","volume":"1","author":"Adam","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion Channel modulators in cystic fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.rmed.2023.107499_bib69","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.202301-0084OC","article-title":"Phase 3 Open-Label Clinical Trial of Elexacaftor\/Tezacaftor\/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele","volume":"208","author":"Goralski","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib71","first-page":"192","article-title":"Elexacaftor-tezacaftor-ivacaftor: the first triple-combination cystic fibrosis transmembrane conductance regulator modulating therapy","volume":"25","author":"Ridley","year":"2020","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.rmed.2023.107499_bib72","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1164\/rccm.202202-0392OC","article-title":"Efficacy and Safety of Elexacaftor\/Tezacaftor\/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: a Phase 3b, Randomized, Placebo-controlled Study","volume":"206","author":"Mall","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40360-022-00624-z","article-title":"Real life evaluation of the multi-organ effects of Lumacaftor\/Ivacaftor on F508del homozygous cystic fibrosis patients","volume":"23","author":"Yaacoby-Bianu","year":"2022","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib74","first-page":"186","article-title":"CFTR modulators: current status and evolving Knowledge","volume":"44","author":"Regard","year":"2022","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPG.0000000000001788","article-title":"Reduction of recurrence risk of pancreatitis in cystic fibrosis with ivacaftor: case series","volume":"66","author":"Carrion","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib76","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2023.107499_bib78","first-page":"25","article-title":"Potential impact on fertility of new systemic therapies for cystic fibrosis","volume":"16","author":"Jones","year":"2015","journal-title":"Paediatr. Respir. Rev."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib79","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2023.107499_bib80","series-title":"North American Cystic Fibrosis Conference; 2022: Journal of Cystic Fibrosis","article-title":"Pregnancies in women with cystic fibrosis with or without intake of elexacaftor\/tezacaftor\/ivacaftor","author":"Naehrig","year":"2022"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2021.03.006","article-title":"Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation","volume":"20","author":"Taylor-Cousar","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"7","key":"10.1016\/j.rmed.2023.107499_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235638","article-title":"The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients","volume":"15","author":"Gostelie","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib83","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/alr.21440","article-title":"Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor","volume":"5","author":"Chang","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.wjorl.2018.09.001","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction","volume":"4","author":"Banks","year":"2018","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib85","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.11-192377","article-title":"Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration","volume":"26","author":"Clunes","year":"2012","journal-title":"Faseb. J."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039809","article-title":"A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease","volume":"7","author":"Sloane","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib87","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.13-0274","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD","volume":"144","author":"Dransfield","year":"2013","journal-title":"Chest"},{"issue":"156","key":"10.1016\/j.rmed.2023.107499_bib88","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0068-2019","article-title":"CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways","volume":"29","author":"Patel","year":"2020","journal-title":"Eur. Respir. Rev."},{"issue":"11","key":"10.1016\/j.rmed.2023.107499_bib89","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/rccm.201304-0733OC","article-title":"Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function","volume":"188","author":"Raju","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"21","key":"10.1016\/j.rmed.2023.107499_bib90","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1074\/jbc.M111.338855","article-title":"Arsenic promotes ubiquitinylation and lysosomal degradation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels in human airway epithelial cells","volume":"287","author":"Bomberger","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib91","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/toxsci\/kfq101","article-title":"Cadmium regulates the expression of the CFTR chloride channel in human airway epithelial cells","volume":"116","author":"Rennolds","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11050384","article-title":"Potential of intestinal current measurement for personalized treatment of patients with cystic fibrosis","volume":"11","author":"Graeber","year":"2021","journal-title":"J. Personalized Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000736","article-title":"Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test","volume":"7","author":"Minso","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib94","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010067","article-title":"Mechanisms of lung damage and development of COPD due to household biomass-smoke exposure: inflammation, oxidative stress, MicroRNAs, and gene polymorphisms","volume":"12","author":"Ortiz-Quintero","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib96","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1152\/japplphysiol.00286.2022","article-title":"Imaging-based assessment of lung function in a population cooking indoors with biomass fuel: a pilot study","volume":"134","author":"Kizhakke Puliyakote","year":"2023","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib97","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1165\/rcmb.2017-0432OC","article-title":"Vaporized E-cigarette liquids induce ion transport dysfunction in airway epithelia","volume":"61","author":"Lin","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5\u20136","key":"10.1016\/j.rmed.2023.107499_bib98","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000094139","article-title":"Arsenic inhibits CFTR-mediated chloride secretion by killifish (Fundulus heteroclitus) opercular membrane","volume":"17","author":"Stanton","year":"2006","journal-title":"Cell. Physiol. Biochem."},{"issue":"2\u20133","key":"10.1016\/j.rmed.2023.107499_bib99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cbi.2008.10.059","article-title":"Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells","volume":"179","author":"Qu","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"9823","key":"10.1016\/j.rmed.2023.107499_bib100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1016\/j.rmed.2023.107499_bib101","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1152\/physrev.1999.79.1.S175","article-title":"Intracellular CFTR: localization and function","volume":"79","author":"Bradbury","year":"1999","journal-title":"Physiol. Rev."},{"issue":"6343","key":"10.1016\/j.rmed.2023.107499_bib102","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/353434a0","article-title":"In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator","volume":"353","author":"Trezise","year":"1991","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.rmed.2023.107499_bib103","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.201908-1550OC","article-title":"Inhaled steroids, circulating eosinophils, chronic airway infection, and pneumonia risk in chronic obstructive pulmonary disease. A network analysis","volume":"201","author":"Martinez-Garcia","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124833","article-title":"Glucocorticoids distinctively modulate the CFTR channel with possible implications in lung development and transition into extrauterine life","volume":"10","author":"Laube","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1513\/AnnalsATS.202008-1054OC","article-title":"Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis","volume":"18","author":"Graeber","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.rmed.2023.107499_bib106","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2023.107499_bib107","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2147\/COPD.S257474","article-title":"Efficacy and safety of the CFTR potentiator icenticaftor (QBW251) in COPD: results from a phase 2 randomized trial","volume":"15","author":"Rowe","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35151-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib109","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1513\/AnnalsATS.201411-518OC","article-title":"Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene","volume":"12","author":"Kim","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chest.2017.10.005","article-title":"CORK study in cystic fibrosis: sustained improvements in ultra-low-dose chest CT scores after CFTR modulation with ivacaftor","volume":"153","author":"Ronan","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib111","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcf.2022.03.011","article-title":"Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis","volume":"21","author":"Wucherpfennig","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib112","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1378\/chest.09-0393","article-title":"The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity","volume":"136","author":"Watz","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib113","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000196539","article-title":"The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections","volume":"63","author":"Loukides","year":"1996","journal-title":"Respiration"},{"issue":"12","key":"10.1016\/j.rmed.2023.107499_bib114","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/crj.13255","article-title":"Impact of diabetes mellitus on the risk of severe exacerbation in patients with chronic obstructive pulmonary disease","volume":"14","author":"Figueira Gon\u00e7alves","year":"2020","journal-title":"Clin. Res. J"},{"key":"10.1016\/j.rmed.2023.107499_bib115","article-title":"Sustained glycemic control with ivacaftor in cystic fibrosis-related diabetes","volume":"7","author":"Christian","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib116","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201405-0882LE","article-title":"Resolution of cystic fibrosis-related diabetes with ivacaftor therapy","volume":"190","author":"Hayes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"42","key":"10.1016\/j.rmed.2023.107499_bib117","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.3748\/wjg.v25.i42.6354","article-title":"Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: a nationwide, population-based study","volume":"25","author":"Lee","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib118","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/13993003.01945-2015","article-title":"Inflammatory bowel disease and risk of mortality in COPD","volume":"47","author":"Vutcovici","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib119","first-page":"1785","article-title":"Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring","volume":"90","author":"Kadakia","year":"1995","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00042737-200012080-00002","article-title":"Smoking and gastro-oesophageal reflux disease","volume":"12","author":"Pandolfino","year":"2000","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.rmed.2023.107499_bib121","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/COPD.S77562","article-title":"Gastroesophageal reflux disease in COPD: links and risks","volume":"10","author":"Lee","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib122","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12890-019-1027-z","article-title":"A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.resinv.2018.01.001","article-title":"Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease","volume":"56","author":"Hasegawa","year":"2018","journal-title":"Respir Investig"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib124","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12931-020-01469-y","article-title":"Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort","volume":"21","author":"Baldomero","year":"2020","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcf.2016.07.004","article-title":"Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation","volume":"16","author":"Zeybel","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib126","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chest.2019.06.036","article-title":"Prevalence and risk factors for osteoporosis in individuals with COPD: a systematic review and meta-analysis","volume":"156","author":"Chen","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib127","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.50130408","article-title":"Current status of research on osteoporosis in COPD: a systematic review","volume":"34","author":"Graat-Verboom","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2023.107499_bib128","doi-asserted-by":"crossref","first-page":"64s","DOI":"10.1183\/09031936.03.00004609","article-title":"Osteoporosis in chronic obstructive pulmonary disease","volume":"46","author":"Ionescu","year":"2003","journal-title":"Eur. Respir. J. Suppl."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thx.2011.160028","article-title":"Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"66","author":"Loke","year":"2011","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib130","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jcf.2016.09.003","article-title":"Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation","volume":"15","author":"Sermet-Gaudelus","year":"2016","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib131","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/genes11050536","article-title":"The microbiome in cystic fibrosis pulmonary disease","volume":"11","author":"Fran\u00e7oise","year":"2020","journal-title":"Genes"},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib133","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2213-2600(18)30510-1","article-title":"Functional effects of the microbiota in chronic respiratory disease","volume":"7","author":"Budden","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2023.107499_bib134","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/COPD.S357491","article-title":"The impact of chronic bronchial infection in COPD: a proposal for management","volume":"17","author":"Martinez-Garcia","year":"2022","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"10","key":"10.1016\/j.rmed.2023.107499_bib135","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib136","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.201210-1843CI","article-title":"Chronic bronchitis and chronic obstructive pulmonary disease","volume":"187","author":"Kim","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib137","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4193\/Rhino11.051","article-title":"Impairment of nasal mucociliary clearance in former smokers with stable chronic obstructive pulmonary disease relates to the presence of a chronic bronchitis phenotype","volume":"49","author":"Koblizek","year":"2011","journal-title":"Rhinology"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib138","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01994-2021","article-title":"C FTR variants are associated with chronic bronchitis in smokers","volume":"60","author":"Saferali","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib139","first-page":"46","article-title":"Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis","volume":"19","author":"Goodwin","year":"2012","journal-title":"Cancer Res. J."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1513\/AnnalsATS.201805-325RL","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: a cross-sectional study","volume":"16","author":"Teerapuncharoen","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmed.2023.107499_bib141","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3389\/fphys.2018.01585","article-title":"Cystic fibrosis of the pancreas: the role of CFTR channel in the regulation of intracellular Ca(2+) signaling and mitochondrial function in the exocrine pancreas","volume":"9","author":"Mad\u00e1csy","year":"2018","journal-title":"Front. Physiol."},{"issue":"130","key":"10.1016\/j.rmed.2023.107499_bib142","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Cavaill\u00e8s","year":"2013","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib143","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD","volume":"32","author":"Mannino","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2023.107499_bib144","first-page":"28","article-title":"Diabetes associated with higher health care utilization and poor outcomes after COPD-related hospitalizations","author":"Belligund","year":"2022","journal-title":"Am. J. Manag. Care"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1172\/JCI116966","article-title":"Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization","volume":"93","author":"Strong","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.rmed.2023.107499_bib146","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/flgastro-2020-101610","article-title":"Cystic fibrosis and the gut","volume":"12","author":"Slae","year":"2021","journal-title":"Frontline Gastroenterol."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib147","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1590\/S1806-37132013000300002","article-title":"Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis","volume":"39","author":"Sakae","year":"2013","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.rmed.2023.107499_bib148","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3389\/fimmu.2020.02144","article-title":"Links between inflammatory bowel disease and chronic obstructive pulmonary disease","volume":"11","author":"Raftery","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2023.107499_bib149","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2340670","article-title":"The gut microbiota and respiratory diseases: new evidence","volume":"2020","author":"Chunxi","year":"2020","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-019-1971-7","article-title":"Smoking and microbiome in oral, airway, gut and some systemic diseases","volume":"17","author":"Huang","year":"2019","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008251","article-title":"CFTR dysregulation drives active selection of the gut microbiome","volume":"16","author":"Meeker","year":"2020","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.rmed.2023.107499_bib152","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14451","article-title":"Comparison of constipation and nutritional status with disease-related parameters in chronic obstructive pulmonary disease patients","volume":"75","author":"G\u00fcrsoy Co\u015fkun","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib153","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcf.2021.05.016","article-title":"Review of gastrointestinal motility in cystic fibrosis","volume":"20","author":"Henen","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"Pt 10","key":"10.1016\/j.rmed.2023.107499_bib154","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1113\/jphysiol.2008.164970","article-title":"The cystic fibrosis transmembrane conductance regulator in reproductive health and disease","volume":"587","author":"Chan","year":"2009","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.rmed.2023.107499_bib155","first-page":"906","article-title":"Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis","volume":"144","author":"Tizzano","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib156","first-page":"119","article-title":"Effect of cigarette smoking on semen quality of infertile men","volume":"48","author":"Gaur","year":"2007","journal-title":"Singap. Med. J."},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib157","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/and.12155","article-title":"Cystic fibrosis transmembrane conductance regulator is correlated closely with sperm progressive motility and normal morphology in healthy and fertile men with normal sperm parameters","volume":"46","author":"Jiang","year":"2014","journal-title":"Andrologia"},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib158","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/humrep\/dep406","article-title":"CFTR is essential for sperm fertilizing capacity and is correlated with sperm quality in humans","volume":"25","author":"Li","year":"2009","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib159","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/REP-13-0146","article-title":"Decreased expression of cystic fibrosis transmembrane conductance regulator impairs sperm quality in aged men","volume":"146","author":"Diao","year":"2013","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib160","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41598-022-05925-1","article-title":"Identification and selection of healthy spermatozoa in heterozygous carriers of the Phe508del-variant of the CFTR-gene in assisted reproduction","volume":"12","author":"De Geyter","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib161","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1439-0272.2000.00327.x","article-title":"CFTR gene mutations and male infertility","volume":"32","author":"Stuhrmann","year":"2000","journal-title":"Andrologia"},{"issue":"7","key":"10.1016\/j.rmed.2023.107499_bib162","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib163","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2009.11.005","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone","volume":"9","author":"Le Heron","year":"2010","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib164","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.4753","article-title":"Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis","volume":"240","author":"Delion","year":"2016","journal-title":"J. Pathol."},{"issue":"Suppl","key":"10.1016\/j.rmed.2023.107499_bib165","first-page":"2","article-title":"Bone health and disease in cystic fibrosis","volume":"20","author":"Marquette","year":"2016","journal-title":"Paediatr. Respir. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib166","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00198-019-05235-9","article-title":"COPD as an independent risk factor for osteoporosis and fractures","volume":"31","author":"Adas-Okuma","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib167","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024951","article-title":"Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study","volume":"9","author":"Akyea","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib168","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1378\/chest.10-1427","article-title":"COPD, bone metabolism, and osteoporosis","volume":"139","author":"Lehouck","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2023.107499_bib169","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2147\/COPD.S79638","article-title":"COPD and osteoporosis: links, risks, and treatment challenges","volume":"11","author":"Inoue","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"9","key":"10.1016\/j.rmed.2023.107499_bib170","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/lt.21545","article-title":"Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation","volume":"14","author":"Rybak","year":"2008","journal-title":"Liver Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib171","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01923-2016","article-title":"Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease","volume":"49","author":"Viglino","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib172","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12931-017-0512-2","article-title":"Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD","volume":"18","author":"Westerik","year":"2017","journal-title":"Respir. Res."},{"issue":"149","key":"10.1016\/j.rmed.2023.107499_bib173","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: dangerous liaisons?","volume":"27","author":"Rabe","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib174","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1378\/chest.12-0938","article-title":"Cardiovascular disease in COPD: mechanisms","volume":"143","author":"Maclay","year":"2013","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2023.107499_bib175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib176","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1038\/s41598-019-43652-2","article-title":"A systematic review of the clinical efficacy and safety of CFTR modulators in cystic fibrosis","volume":"9","author":"Habib","year":"2019","journal-title":"Sci. Rep."},{"issue":"44","key":"10.1016\/j.rmed.2023.107499_bib177","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib178","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1513\/AnnalsATS.202101-057OC","article-title":"Impact of cystic fibrosis transmembrane conductance regulator therapy on chronic rhinosinusitis and health status: deep learning CT analysis and patient-reported outcomes","volume":"19","author":"Beswick","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib179","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib180","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.10-2077","article-title":"Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment","volume":"139","author":"Rogan","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2023.107499_bib181","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202303-0458OC","article-title":"Icenticaftor, a CFTR potentiator, in COPD: a multicenter, parallel-group, double-blind clinical trial","volume":"208","author":"Martinez","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib182","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49544-9","article-title":"Cigarette smoke exposure induces retrograde trafficking of CFTR to the endoplasmic reticulum","volume":"9","author":"Marklew","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.rmed.2023.107499_bib183","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcf.2020.11.002","article-title":"Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)","volume":"20","author":"Kazani","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"19","key":"10.1016\/j.rmed.2023.107499_bib184","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107499_bib185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.rmed.2023.107499_bib186","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201509-1722PP","article-title":"Plasma fibrinogen qualification as a drug development tool in chronic obstructive pulmonary disease. Perspective of the chronic obstructive pulmonary disease biomarker qualification consortium","volume":"193","author":"Miller","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib187","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12931-021-01706-y","article-title":"InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations","volume":"22","author":"Singh","year":"2021","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.rmed.2023.107499_bib188","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/thoraxjnl-2012-201871","article-title":"Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease","volume":"68","author":"Duvoix","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2023.107499_bib189","doi-asserted-by":"crossref","first-page":"2101581","DOI":"10.1183\/13993003.01581-2021","article-title":"Evaluation of a novel CFTR potentiator in copd ferrets with acquired cftr dysfunction","volume":"60","author":"Kaza","year":"2021","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123003876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123003876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:09:42Z","timestamp":1767236982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611123003876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":188,"alternative-id":["S0954611123003876"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107499","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential systemic effects of acquired CFTR dysfunction in COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107499"}}